Episode 281: Paper of The Month - Lu-177 With Pembrolizumab in Prostate Cancer

Rahul Aggarwal, MD, joins the podcast to discuss his recent paper on a phase 1/2 study that utilized a single priming dose of lutetium followed by maintenance pembrolizumab in patients with metastatic CRPC.
Dr. Aggarwal is Associate Director for Clinical Sciences at the UCSF Helen Diller Family Comprehensive Cancer Center, as well as an Associate Professor of Hematology/Oncology at UCSF.